Founded with the vision of unleashing the full potential of genetic science, Skyline Therapeutics brings together a world-class team of experts and leaders in science, technology, and business to tackle some of today’s toughest scientific challenges.
The Skyline team’s capabilities span capsid discovery, vector engineering and design, in-vivo pharmacology, clinical development, analytical and process development, and CMC.